Neil Glat
FuboTVAbout Neil Glat
Independent director since March 2024; age 57. Glat chairs Fubo’s Compensation Committee and sits on the Nominating & Corporate Governance Committee, bringing 25+ years of sports/media operating and strategic experience (NFL corporate development/strategy; President, New York Jets; Co‑President, Americas at SPORTFIVE). He holds a BS in Economics from Wharton and a JD from Harvard Law School .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| National Football League (NFL) | Senior executive overseeing corporate development and strategy | ~15 years (prior to 2012) | Led G-3 stadium financing program; launched 32 Equity growth fund |
| New York Jets | President; then Senior Advisor | Apr 2012–Aug 2019; Sep 2019–Mar 2020 | Drove business ops; MGM gaming partnership; Jets Rewards loyalty program |
| SPORTFIVE | Co‑President, Americas | Dec 2021–Feb 2024 | Growth/marketing leadership across sports properties |
| McKinsey & Company | Management consultant | Prior to NFL tenure | Strategic advisory (consulting) |
| Dillon, Read & Co. | Investment banker | Prior to NFL tenure | Corporate finance/transactions |
External Roles
| Organization | Role | Tenure | Committees/Notes |
|---|---|---|---|
| Evolv Technology (NASDAQ: EVLV) | Board Chair | Nov 2023–present | Investment and Nominating & Corporate Governance Committees |
| ASM Global (private) | Director | 2019–Aug 2024 (company sold Aug 2024) | Largest global venue manager; board service concluded on sale |
| Arctos Sports Partners (private equity) | Senior Advisor | Prior/present (dates not specified) | PE advisory focused on pro sports |
| NewHold Investment Corp. I (SPAC) | Director | Jul 2020–Jul 2021 | Public SPAC board |
| NewHold Investment Corp. II (SPAC) | Director; Chair of Nominating & Corporate Governance | Oct 2021–Apr 2023 | Public industrial tech SPAC |
Board Governance
- Independence: Board affirmatively determined Glat is independent under NYSE rules .
- Committee assignments: Compensation Committee Chair; Nominating & Corporate Governance Committee member (table below). The Compensation Committee met 7 times in 2024, Nominating met 4, Audit met 4; Board held 19 meetings, and all directors attended ≥75% of Board/committee meetings .
- Executive sessions: Independent directors meet in executive session regularly; committee chairs rotate presiding; Audit Chair presides for independent director sessions .
| Committee | Role | 2024/2025 Detail |
|---|---|---|
| Compensation | Chair (current) | Committee duties include CEO/executive pay oversight, equity plan administration, HCM oversight; independence confirmed; 7 meetings in 2024 |
| Nominating & Corporate Governance | Member | Duties include board composition, independence, succession, ESG oversight; 4 meetings in 2024 |
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Annual cash retainer | $50,000 | Standard non‑employee director base fee |
| Compensation Committee member fee (2024) | $9,500 | Member (chair fee is $20,000; Glat became chair subsequently) |
| Nominating & Corporate Governance Committee member fee | $6,000 | Member fee |
| 2024 cash actually earned | $53,879 | Pro‑rated based on March 5, 2024 appointment; director compensation table |
Performance Compensation
| Equity Element | Grant Value | Vesting | Notes |
|---|---|---|---|
| Initial RSU award | $330,000 | 3 equal annual installments | Granted on appointment; shares = $330,000 / 30‑day average share price; subject to service |
| Annual RSU award | $228,000 | Vests in full at next annual meeting or 1‑year mark | Eligible only after ≥6 months of service |
| 2024 stock awards (fair value) | $256,530 | As granted | Reported under ASC 718; director compensation table |
| Change‑in‑control | Full acceleration of director awards | On CoC, with continued service through CoC date | Under Outside Director Compensation Policy |
| Clawback | Subject to company clawback policy | Applies to awards | NYSE/Dodd‑Frank compliant clawback provisions |
Performance metrics table (directors): Director equity awards are time‑based; no performance metrics apply to non‑employee director grants. Annual/initial RSUs vest based on continued service; no revenue/EBITDA/TSR hurdles disclosed for directors .
Other Directorships & Interlocks
| Company | Overlap/Interlock Risk | Comment |
|---|---|---|
| Evolv Technology (EVLV) | Low | Security screening tech; no Fubo related‑party transactions disclosed for 2024–proxy date |
| ASM Global | Low | Venue management; no Fubo related‑party transactions disclosed |
| SPAC boards (NewHold I/II) | Low | Past service; no Fubo related‑party transactions disclosed |
Expertise & Qualifications
- Deep sports/media operating experience (NFL corporate development/strategy; President of NY Jets; SPORTFIVE Co‑President Americas) with revenue growth, consumer engagement, innovation, and transaction execution track record .
- Public board leadership (EVLV Board Chair) and prior SPAC board governance; legal and finance training (Wharton BS Econ; Harvard JD) .
Equity Ownership
| Item | Amount | Detail |
|---|---|---|
| Shares beneficially owned | 74,144 | Direct ownership as of April 22, 2025; <1% of outstanding |
| RSUs outstanding (12/31/2024) | 147,431 | Unvested RSUs at year‑end 2024 |
| Options outstanding | None | No options reported for Glat |
| Ownership % | <1% | Based on 341,539,797 shares outstanding |
| Hedging/Pledging | Prohibited | Company policy prohibits hedging and pledging; Insider Trading Policy applies to directors |
Insider Trades
| Filing | Date | Summary |
|---|---|---|
| Form 3 (Initial Statement) | Mar 6, 2024 | Filed on appointment; reported no securities beneficially owned at that time |
| Proxy beneficial ownership update | Apr 22, 2025 record date | Shows 74,144 shares held directly; RSUs outstanding 147,431 (as of 12/31/2024) |
Governance Assessment
- Board effectiveness and engagement: Glat’s elevation to Compensation Committee Chair (with 7 committee meetings in 2024) and dual service on Nominating & Corporate Governance underscores active governance participation and expertise in pay/human capital oversight .
- Independence and attendance: Independent under NYSE; Board met 19 times in 2024 and all directors met ≥75% attendance, supporting robust oversight cadence .
- Compensation alignment: Director pay mixes cash retainer and time‑based RSUs with change‑in‑control acceleration; plan limits director equity to $750,000 per year ($1.5M in initial service year) and prohibits option repricing and tax gross‑ups—shareholder‑friendly features .
- Ownership alignment and policies: Direct holdings are modest (<1%), supplemented by unvested RSUs. Company prohibits hedging/pledging and applies clawback, mitigating misalignment risks .
- Conflicts/related‑party exposure: Proxy reports no director material interests or related‑party transactions for 2024 through proxy date; interlocks (EVLV, ASM Global) present limited conflict risk given Fubo’s business and oversight processes (Audit Committee reviews related‑party transactions) .
- Investor confidence signals: Say‑on‑pay support improved to ~89% in 2024 (80% in 2023; prior 99%/95%), reflecting responsiveness to shareholder feedback on compensation design—relevant to Glat’s remit as Compensation Chair .